Publicaciones en las que colabora con Rafael Pulido Murillo (9)

2024

  1. Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy

    Cancers, Vol. 16, Núm. 16

2023

  1. Author Correction: The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma (Scientific Reports, (2023), 13, 1, (7339), 10.1038/s41598-023-34087-x)

    Scientific Reports

  2. The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma

    Scientific Reports, Vol. 13, Núm. 1

2021

  1. (Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder

    Cancers, Vol. 13, Núm. 22

2019

  1. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder

    Human Pathology, Vol. 91, pp. 61-68

2018

  1. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma

    Annals of Diagnostic Pathology, Vol. 34, pp. 27-30

2016

  1. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma

    Human Pathology, Vol. 54, pp. 100-105

  2. Low-grade metastases in high-grade clear cell renal cell carcinomas A clinicopathologic study of 4 cases with an insight into the role of mesenchymal-to-epithelial transition process

    Annals of Diagnostic Pathology, Vol. 20, pp. 13-18

  3. The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases

    PLoS ONE, Vol. 11, Núm. 12